Nuzenio

Nda Submission

Nda Submission news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 8 publisher sources 100/100 entity strength

Latest news

XENE Advances Pipeline with NDA Submission Plans Amid High Price-to-Sales Valuation - GuruFocusGuruFocus · Fri, 07 Aug 2026 03:21:23 GMTXenon’s epilepsy drug FDA filing is on track for Q3 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 23:02:30 GMTStoke: 'Buy' Zorevunersen NDA SCN1A DS And STK-002 Advancement (NASDAQ:STOK) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 17:50:02 GMTCompass Pathways reports Q2 2026 net loss $253.8M, cash $433.3M; NDA rolling with launch targeted H1 2027 - TradingViewTradingView · Wed, 05 Aug 2026 10:33:01 GMTPVLA: Advanced NDA submission and clinical pipeline with $250.6M cash; net loss widened to $21.9M - TradingViewTradingView · Tue, 04 Aug 2026 12:08:12 GMTPalvella Reports Q2 Net Loss and Advances QTORIN NDA Plans - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:36:00 GMTStoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates - BioSpaceBioSpace · Tue, 04 Aug 2026 02:30:55 GMTStoke Therapeutics reports Q2 2026 net loss $61.6M, $420M cash runway; Phase 3 zorevunersen enrollment complete - TradingViewTradingView · Mon, 03 Aug 2026 20:13:01 GMT

Timeline

Fri, 07 Aug 2026 03:21:23 GMTXENE Advances Pipeline with NDA Submission Plans Amid High Price-to-Sales Valuation - GuruFocus
Thu, 06 Aug 2026 23:02:30 GMTXenon’s epilepsy drug FDA filing is on track for Q3 2026 - Stock Titan
Wed, 05 Aug 2026 17:50:02 GMTStoke: 'Buy' Zorevunersen NDA SCN1A DS And STK-002 Advancement (NASDAQ:STOK) - Seeking Alpha
Wed, 05 Aug 2026 10:33:01 GMTCompass Pathways reports Q2 2026 net loss $253.8M, cash $433.3M; NDA rolling with launch targeted H1 2027 - TradingView
Tue, 04 Aug 2026 12:08:12 GMTPVLA: Advanced NDA submission and clinical pipeline with $250.6M cash; net loss widened to $21.9M - TradingView
Tue, 04 Aug 2026 11:36:00 GMTPalvella Reports Q2 Net Loss and Advances QTORIN NDA Plans - Quiver Quantitative

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nda Submission.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.